Amgen (AMGN) free cash flow

Free cash flow · fiscal 2025
$8.10B

Amgen (AMGN) generated free cash flow of $8.10B in fiscal 2025 (the year ended December 31, 2025). That is 22.1% lower than the $10.39B of fiscal 2024. Figures as of 18 Nov 2026, 12:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$8.10B
Change on fiscal 2024
−22.1%
Growth, 5 years
−3.9% a year
Growth, 10 years
−1.2% a year
Highest on record
$10.56Bfiscal 2018
Lowest on record
$4.13Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amgen free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 3.9% a year; over ten years the rate was −1.2% a year. Across the 19 fiscal years on record (2007–2025), the highest was $10.56B in fiscal 2018 and the lowest $4.13B in fiscal 2007.

History · 19 fiscal years

Free cash flow by fiscal year

Amgen free cash flow, year by year

Amgen (AMGN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$8.10B 22.1% down
2024$10.39B 41.2% up
2023$7.36B 16.2% down
2022$8.79B 4.8% up
2021$8.38B 15.2% down
2020$9.89B 15.9% up
2019$8.53B 19.2% down
2018$10.56B 0.4% up
2017$10.51B 9.3% up
2016$9.62B 5.2% up
2015$9.14B 11.0% up
2014$8.23B 47.1% up
2013$5.60B 7.8% up
2012$5.19B 14.1% up
2011$4.55B 12.6% down
2010$5.21B 10.3% down
2009$5.81B 9.2% up
2008$5.32B 28.6% up
2007$4.13B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Amgen and comparable companies
CompanyFree cash flowFiscal year
Novartis NVS$15.24B2025
AstraZeneca AZN$8.67B2025
Thermo Fisher Scientific TMO$6.29B2025
Amgen AMGN$8.10B2025
Gilead Sciences GILD$9.46B2025
Abbott Laboratories ABT$7.40B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMGN

Amgen, figure by figure

Amgen (AMGN) overview: price, valuation and scorecardAll health care companies by market value

Amgen free cash flow: questions and answers

What is Amgen's free cash flow?

Amgen (AMGN) generated free cash flow of $8.10B in fiscal 2025 (the year ended December 31, 2025). That is 22.1% lower than the $10.39B of fiscal 2024.

What is the growth rate of Amgen's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 3.9% a year; over ten years the rate was −1.2% a year.

What are the highest and lowest free cash flow figures on record for Amgen?

Across the 19 fiscal years on record (2007–2025), the highest was $10.56B in fiscal 2018 and the lowest $4.13B in fiscal 2007.

How is Amgen's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Amgen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amgen (AMGN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AMGN/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.